Vanda Pharmaceuticals

Yahoo Finance • 2 days ago

FDA re-review of Vanda tradipitant partial clinical hold extended

[FDA Headquarters] * The US FDA is extending by a matter of days a re-review of a partial clinical hold on long-term studies of Vanda Pharmaceuticals' (VNDA [https://seekingalpha.com/symbol/VNDA]) tradipitant for motion sickness. * Th... Full story

Yahoo Finance • 12 days ago

Vanda Pharmaceuticals Surges 21% After Positive Tradipitant Trial In GLP-1 Adjunct Setting

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) jumped 21.02% to $5.32, up $0.92, after announcing positive topline results from its phase III study of tradipitant in preventing nausea and vomiting induced by GLP-1 agonists in overweight and... Full story

Yahoo Finance • 12 days ago

Vanda's tradipitant can significantly reduce nausea in those taking a GLP-1

[Curvy woman feeling nauseous having stomach ache] Antonio_Diaz/iStock via Getty Images * A phase 2 trial of Vanda Pharmaceuticals' (VNDA [https://seekingalpha.com/symbol/VNDA]) tradipitant found that the oral therapy tradipitant signif... Full story

Yahoo Finance • last month

Jim Cramer on Vanda Pharmaceuticals: “I’m Going to Bless That One as Your Spec”

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is one of the stocks on Jim Cramer’s radar recently. When Cramer was asked about the stock toward the end of the lightning round, he said: “Well, look, here’s the way I feel about Vanda. This is a... Full story

Yahoo Finance • 2 months ago

Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena

Multiyear agreement includes exclusive Monumental Sports Network studio entitlement, activations across Capitals, Wizards, and Mystics, and deep integration via community and media platforms For photos of the new Vanda Pharmaceuticals Stu... Full story

Yahoo Finance • 3 months ago

US High Growth Tech Stocks to Watch This August 2025

As of August 2025, the U.S. stock market is experiencing a remarkable upswing, with key indices like the S&P 500 and Dow Jones Industrial Average reaching record highs amid anticipation of a significant inflation report. In this thriving e... Full story

Yahoo Finance • 4 months ago

Vanda earnings missed by $0.17, revenue fell short of estimates

Investing.com - Vanda (NASDAQ: VNDA) reported second quarter EPS of $-0.46, $0.17 worse than the analyst estimate of $-0.29. Revenue for the quarter came in at $52.59M versus the consensus estimate of $55.1M. Guidance Vanda sees FY 2025... Full story

Yahoo Finance • 4 months ago

Vanda Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY25 outlook

* Vanda Pharmaceuticals press release [https://seekingalpha.com/pr/20184460-vanda-pharmaceuticals-reports-second-quarter-2025-financial-results] (NASDAQ:VNDA [https://seekingalpha.com/symbol/VNDA]): Q2 GAAP EPS of -$0.46 misses by $0.10.... Full story

Yahoo Finance • 4 months ago

Voice actors push back as AI threatens dubbing industry

By Elizabeth Pineau, Miranda Murray and Dawn Chmielewski PARIS/BERLIN (Reuters) -Boris Rehlinger may not turn heads on the streets of Paris, but his voice is instantly recognisable to millions of French filmgoers. As the French voice of... Full story

Yahoo Finance • 4 months ago

Oil pauses rally as markets weigh Trump's ultimatum to Russia

By Mohi Narayan and Colleen Howe NEW DELHI (Reuters) -Oil prices took a breather in Asian trade on Wednesday after the previous session’s spike of more than 3%, as investors awaited developments from U.S. President Donald Trump’s tighter... Full story

Yahoo Finance • 4 months ago

Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues

(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme (NASDAQ:DNUT) and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into depa... Full story

Yahoo Finance • 4 months ago

Analysis-Institutional investors warm to crypto but demand still nascent

By Suzanne McGee, Niket Nishant and Manya Saini NEW YORK (Reuters) -Bitcoin’s surge to a record this week has reignited questions about the role institutional investors are playing in pushing it higher, with analysts suggesting their role... Full story

Yahoo Finance • 10 months ago

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular PsoriasisVanda expects to immediately begin preparing BLA and MAA applications for the US and EUAnaptys to receive $15 million from Vanda, comprised... Full story

Yahoo Finance • 2 years ago

Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology Journal

WASHINGTON, Jan. 25, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase I... Full story

Yahoo Finance • 2 years ago

Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results

Total revenues in the first nine months of 2023 were $147.4 million Vanda provides update on pipeline advancements and regulatory plans WASHINGTON, Nov. 8, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today anno... Full story

Yahoo Finance • 3 years ago

Q1 2023 Vanda Pharmaceuticals Inc Earnings Call

Participants Kevin Patrick Moran; Senior VP, CFO & Treasurer; Vanda Pharmaceuticals Inc. Mihael H. Polymeropoulos; Founder, President, CEO & Chairman of The Board; Vanda Pharmaceuticals Inc. Timothy Williams; Senior VP, General Counsel... Full story

Yahoo Finance • 3 years ago

VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDER

WASHINGTON, Sept. 7, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the notice of opportunity for an FDA hearing on Vanda's Supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon) to trea... Full story

Yahoo Finance • 4 years ago

Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022

Conference Call and Webcast to Follow WASHINGTON, April 28, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2022 on Thursday, May 5, 2022, after the mark... Full story